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Purpose: To compare the epithelial wound healing response of two preservative-
free fluoroquinolones, moxifloxacin and levofloxacin, in patients who underwent 
cataract surgery. Materials and Methods: In this prospective, evaluator-masked, 
randomized clinical trial, 59 eyes of 50 patients who underwent cataract surgery 
were enrolled. Patients were randomized to receive moxifloxacin 0.5% (n=32 eyes) 
or levofloxacin 0.5% (n=27 eyes). All patients instilled moxifloxacin or levoflox-
ain four times daily for 1 week prior to surgery and 2 weeks after surgery. The epi-
thelial wound healing status in the corneal incision site was scanned with a raster 
scan mode of fourier-domain optical coherence tomography (FD-OCT). The num-
ber of eyes showing epithelial defect images and average number of corneal epi-
thelial defect cuts per eye were compared between groups. All patients were evalu-
ated on postoperative days 1, 2, 3, and 10. Results: On postoperative days 1, 2, 
and 3, the number of eyes showing epithelial defects in FD-OCT was not statisti-
cally different (all p>0.05). The average number of corneal epithelial defect cuts 
was also not statistically different between the two groups (all p>0.05). No eyes 
showed epithelial defects on postoperative day 10 in either group. Conclusion: 
There were no differences on epithelial wound healing comparing these two dif-
ferent fluoroquinolones at the incision site of cataract surgery.
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INTRODUCTION
The selection of appropriate antibiotic eye drops is critical for preventing endo-
phthalmitis, one of the most detrimental complications after cataract surgery. Fluo-
roquinolones have long been used for the prevention of postoperative infections, 
but resistance to third-generations fluoroquinolones led to the introduction and de-
velopment of fourth-generation fluoroquinolones (moxifloxacin or gatifloxacin). 
Moxifloxacin and gatifloxacin have demonstrated 2- to 3-fold penetration into the 
anterior chamber, improved activity against atypical mycobacteria, and greater an-
tibacterial effects against gram-positive bacteria compared to second-generation 
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surgeon (E.K.K.) performed all surgical procedures. A sin-
gle investigator (W.S.C.), under the same conditions, evalu-
ated the postsurgical wound. 
The inclusion criteria for this study were patients >18 
years age who were scheduled for removal of a cataract and 
implantation of a posterior chamber intraocular lens (IOL), 
intraocular pressure ≤20 mm Hg prior to surgery, and had 
otherwise normal and healthy eyes aside from cataracts as 
determined by ophthalmic examination. Patients with any 
of the following conditions were not eligible to participate 
in this clinical trial: fluorescein staining of the cornea be-
fore surgery, history of any ocular diseases including ocular 
inflammatory diseases, ocular herpes infection, iritis, uve-
itis, Sjögren’s syndrome, corneal dystrophy, uncontrolled 
diabetes and/or diabetic retinopathy, any history of systemic 
disease such as autoimmune diseases, history of treatment 
for an ocular infection within 30 days prior to study entry, 
use of topical or systemic steroids within 7 days prior to 
study entry, use of topical anti-inflammatory drugs within 7 
days prior to study entry, known or suspected allergy or hy-
persensitivity to levofloxacin or any related medicines, such 
as cinoxacin, ciprofloxacin, norfloxacin, ofloxacin, or nali-
dixic acid, preservatives, dyes, or any component of the 
medications involved in the study, pregnancy, nursing/lacta-
tion, or inadequate birth control methods. Oral contraceptive 
use was allowed. Patients with any cataract wounds requir-
ing sutures or corneal burn secondary to the phacoemulsifi-
cation handpiece were excluded in this study. 
Surgical procedure
Patients were instructed to use the assigned antibiotics, mox-
ifloxacin or levofloxacin, four times a day for 1 week prior 
to surgery. Standard phacoemulsification with a 2.2 mm 
clear corneal 3-plane incision was performed. Each corneal 
incision was made with a disposable phacoblade (Slu-
22AGF®, Kai medical, Gifu, Japan). The length of the cor-
neal incision was set at 2 mm or greater for self-sealing. A 
2.2 mm microcoaxial phaco-handpiece (No. 8065750853, 
Alcon, Fort Worth, TX, USA) was used for phacoemulsifi-
cation. After irrigation and aspiration of the cortex, a poste-
rior chamber intraocular lens (Acrysof SN60WF, Alcon, 
Fort Worth, TX, USA) was inserted into the capsular bag. 
At the end of surgery, the corneal wound was sealed with 
stromal hydration. If any wound leak was observed, the 
corneal wound was sutured with 10-0 nylon sutures, and 
the patient was excluded from the study. An eye patch was 
then placed over the for 6 hours and then removed. Patients 
(ciprofloxacin and ofloxacin) or third-generation (levoflox-
acin) fluoroquinolones.1,2 Adverse epithelial cytotoxic ef-
fects, however, should also be considered when choosing 
antibiotics because rapid re-epithelialization helps to pre-
vent microbial invasion and other possible complications 
such as epithelial ingrowth.3,4
Moxifloxacin and levofloxacin are commonly used anti-
biotic eye drops after cataract surgery or refractive proce-
dures. Although there have been several reports comparing 
effects on epithelial wound healing of various fluoroquino-
lones as well as their potential cytotoxicity,5-8 the results 
were not consistent. These studies also compared fluoroqui-
nolones that contain the preservative, benzalkonium chlo-
ride (BAK), with fluoroquinolones without BAK. BAK it-
self has been reported beneficial in helping to prevent 
bacterial growth at a rate faster than preservative-free fluo-
roquinolones, especially against gram-positive bacteria.9 
However, BAK is known to cause corneal and/or conjunc-
tival epithelial toxicity.10,11 Moreover, to our knowledge, 
there is no study comparing these two types of topical fluo-
roquinolones in human eyes after cataract surgery.
To compare the intrinsic effects of third- and fourth-gener-
ation fluoroquinolones without the influence of BAK on the 
re-epithelialization of corneal incision sites after cataract 
surgery, we compared the effects of two commercially avail-
able preservative-free fluoroquinolones, moxifloxacin (Vi-
gamox®, Alcon Laboratories, Fort Worth, TX, USA) and le-
vofloxacin (Cravit®, Santen, Osaka, Japan). 
MATERIALS AND METHODS
　　　
This study was a prospective, single-masked, randomized, 
comparative evaluation of patients undergoing phacoemul-
sification. All participants signed an informed consent after 
a detailed explanation of the study. This study was prospec-
tively approved by the Institutional Review Board of Sev-
erance Hospital and followed the tenets of the Declaration 
of Helsinki. 
The investigator assigned the operated eye of each pa-
tient with an identification number that corresponded to a 
treatment regimen based on a randomization scheme creat-
ed at baseline. The patients then received the appropriate 
treatment regimen for their identification number based on 
this randomization scheme. This allowed the investigator to 
be blinded as to which treatment regimens were allocated 
to patients. To minimize inter-surgeon variability, a single 
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without interruption were interpreted as a non-defect cut 
(Fig. 2B). 
In eyes showing epithelial defects, the degree of wound 
healing was determined based on the number of defect cuts 
on the FD-OCT image (Fig. 1C). The proportion of eyes 
that showed epithelial defects and the average number of de-
fect cuts (the total number of defect cuts found in each 
group/the number of patients with defect cuts in each group) 
were compared between the two groups.
Statistical analysis
All data was analyzed by a statistician not involved in the 
study design or collection of data. Statistical analyses were 
performed using PASW for Windows (version 18.0, SPSS 
Inc., Chicago, IL, USA). Average values of parameters 
were compared using either the chi-square test or Fisher’s 
exact test. A p value less than 0.05 was considered statisti-
cally significant.
 
RESULTS
 
Participants 
Eighty-four eyes of 72 patients were initially included. Nine 
patients receiving cataract surgery on both eyes had a peri-
were asked to instill the assigned antibiotic four times per 
day. Prednisolone acetate 1% (Pred-Forte®, Allergan, Inc., 
Irvine, CA, USA) was also instilled four times per day con-
currently. After 2 weeks, eye drop use was discontinued. Pa-
tients were evaluated on postoperative days 1, 2, 3, and 10.
Measurement of epithelial wound healing
Epithelial defect size can vary in accordance with elapsed 
time after staining and strength of illumination (Fig. 1A). 
To obtain more objective information with regards to both 
the length and depth of epithelial defect, the corneal inci-
sion site was scanned with the raster scan mode of FD-
OCT, which provides 17 cross-sectional images in a size 
adjustable square that measured 3×3 mm2, resulting in 17 
focal points each measured at 0.187 mm intervals in that 
square (Fig. 1B). 
An epithelial defect cut was defined when an interruption 
or lack of epithelial growth (a black hollow space in the in-
cision site, white arrows in Fig. 2A-1 and A-2) was found 
in the FD-OCT image above the extension line, an imagi-
nary extension line between the cut edges of Bowman lay-
er (red dotted line of Fig. 2A and B). Images showing a 
continuous epithelial growth (a dark gray space connected 
with the epithelium which showing similar dark gray col-
or, black arrows in Fig. 2B-1 and B-2) above this line 
A
B
C-1
C-2
C-3
C-4
Fig. 1. (A) A slit lamp photograph of the corneal incision after fluorescence dye staining. The margin of corneal defect is obscure (a or b) 
and can be interpreted differently according to varying strengths of illumination. (B) A capture window of raster scan mode in fourier-do-
main optical coherence tomography (FD-OCT). By selecting a 3×3 mm2 sized capture window, 17 cuts of cross-sectional images (white 
and red arrows) could be acquired at the same gap. (C) On cross-sectional images of red arrows in Fig. 1B, the defect cuts (C-1 to 4) can 
be counted. The actual margin of corneal defect detected based on the FD-OCT images was determined to be “a” not “b” in Fig. 1A.
Defect cut
Defect cut
Defect cut
Defect cut
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floxacin group; 64.6±8.7 years, p>0.05). There were no 
postoperative complications in these patients during the 10 
days of follow-up after successful phacoemulsification and 
IOL implantation. 
Incidence of epithelial defect
On the first day after the operation, 15 of 32 eyes (46.9%) 
of the moxifloxacin group and 17 of 27 eyes (63.0%) of the 
levofloxacin group showed at least one corneal epithelial 
defect cut, but the difference was not statistically significant 
(p=0.217, chi-square test) (Table 1). On postoperative day 
2, five eyes (15.6%) in the moxifloxacin group and one eye 
(3.7%) in the levofloxacin group showed corneal epithelial 
defect cuts, but the difference was not statistically signifi-
cant (p=0.205, Fisher’s exact test). On postoperative day 3, 
one eye (3.1%) in the moxifloxacin group showed corneal 
epithelial defect cuts and there was no eye showing an epi-
thelial defect cut in the levofloxacin group. There was no 
statistically significant differences between the two groups 
(p=0.542, Fisher’s exact test). On postoperative day 10, no 
eye had an epithelial defect cut in either group. 
od of at least two weeks between each cataract surgery, with 
each eye being treated as a new case. Among the initial 84 
eyes, 25 eyes were excluded for the following reasons: can-
cellation of surgery due to personal reasons (15 eyes), suture 
placement after surgery due to wound leakage (nine eyes), 
and occurrence of posterior capsule rupture (one eye). Final-
ly, 59 eyes of 51 patients were enrolled upon completion of 
the study; 32 eyes received moxifloxacin and 27 eyes re-
ceived levofloxacin. The mean age of the 51 patients was 
65.1±8.0 years (moxifloxacin group; 65.4±7.4 years, levo-
A B
Fig. 2. (A) Representative images showing the defect and non-defect image cuts in images of the fourier-domain optical coherence to-
mography. (A and B) An imaginary line (red dotted line) was drawn connecting Bowman layer on both ends of the sectional plane. (A-1 
and A-2) Cases showing a lack of epithelium on the imaginary line and a discontinuation of this line were interpreted as a defect cut. The 
black hollow spaces without epithelial growth were noted (white arrows). The layer of powerfully bright light is considered to be a reflec-
tion of the tear fluid (white hollow arrowheads). (B-1 and B-2) Cases showing epithelial growth both above this line and without interrup-
tions were interpreted as a non-defect image cut. The spaces in the incision site were occupied with epithelial growth which showing 
similar dark gray color with the epithelial layer (black arrows). 
A-1 B-1
A-2 B-2
Non-defect cutDefect cut
Table 1. Number of Eyes with Corneal Epithelial Defect Cuts 
after Cataract Surgery
Moxifloxacin 
(n=32) Eyes (%)
Levofloxacin 
(n=27) Eyes (%)
p value
Postoperative day
    1 15 (46.9) 17 (63.0)  0.217*
    2   5 (15.6)   1 (3.7) 0.205†
    3   1 (3.7)   0 (0) 0.542†
    10   0 (0)   0 (0) -
*Chi-square test.
†Fisher’s exact test.
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ofloxacin, levofloxacin, gatifloxacin, or ciprofloxacin on 
healthy rabbit corneas, and showed that moxifloxacin 
caused the least damage to the corneal epithelium. Never-
theless, in the last two studies mentioned, moxifloxacin was 
the only solution that did not contain BAK. Because the ef-
fect of BAK was not excluded in those studies, the authors 
presumed the cytotoxicity of fluoroquinolones was mainly 
a result of the preservatives and not of the fluoroquinolone 
itself.
To exclude these interfering effects of BAK, we have 
chosen commercially available and preservative-free mox-
ifloxacin and levofloxacin, and our results showed there 
were no statistical differences in epithelial wound healing 
in clear corneal incision. This is consistent with an in vivo 
study that used the same preservative-free fluoroquino-
lones as we studied, in which Watanabe, et al.14 treated 
healthy human volunteers with either moxifloxacin or le-
vofloxacin three times per day for 1 week and reported that 
there were no differences in tear break-up time and mor-
phological appearance of the corneal epithelium, stroma, 
and endothelium. 
In this study, we used a clear corneal incision model to 
compare the effect of two different topical fluoroquinolones 
on wounded human corneas. As these patients were already 
scheduled for cataract surgery, the corneal incisions in this 
study posed no ethical problems and it was an appropriate 
model that could induce the standardized form of epithelial 
damage. Through this model, epithelial defects of the same 
length were made, and the rate of re-epithelialization could 
be compared. 
Accurate epithelial defect measurements could not be as-
certained when using fluorescein dye staining because 
sometimes distinguishing between true epithelial defect and 
wound irregularity after epithelial healing is difficult. In ad-
dition, quantitative measurements of the degree of wound 
healing, as shown in Fig. 1A, can also be difficult. In this 
study, we used anterior segment FD-OCT to measure epi-
thelial defects. Using FD-OCT, we could quantitatively 
measure the epithelial defect from focal points measured at 
0.187 mm intervals. Thus, the length of epithelial defect 
could be measured more accurately. 
The current study is the first to compare corneal epithelial 
wound healing in human eyes after cataract surgery with 
topical use of moxifloxacin and levofloxacin. Our study 
showed that there was no significant difference between 
these two antibiotics in terms of their effect on re-epitheliali-
zation after cataract surgery. 
The mean number of defect cuts per eye
Because individual variance of epithelial defect size exist-
ed, we evaluated the mean number of epithelial defect cuts 
per eye (the total number of epithelial defect cuts/the num-
ber of eyes with epithelial defect) and compared the values 
between the groups. 
On postoperative day 1, the mean number of defect cuts 
per eye was 3.93±2.34 (range: 1-9 per eye) in the moxiflox-
acin group and 2.82±1.67 (range: 1-7 per eye) in the levo-
floxacin group. On postoperative day 2, the mean number 
of defect cuts per eye was 1.60±1.34 (range: 1-5 per eye) in 
the moxifloxacin group and 1 (1 cut/1 eye) in the levofloxa-
cin group. On postoperative day 3, the mean number of de-
fect cuts per eye was two (2 cuts/1 eye) in the moxifloxacin 
group and none (0 cut/0 eye) in the levofloxacin group. On 
postoperative day 10, there was no defect cut in either group. 
There were no statistically significant differences through 
the follow-up examinations (all p>0.05).
DISCUSSION
In this study, there were no significant differences in the 
number of eyes showing epithelial defects between the 
moxifloxacin and levofloxacin groups on days 1, 2, 3, and 
10 after cataract surgery. There was also no statistical dif-
ference in the average number of defect cuts per eye be-
tween the two groups on follow-up examinations. 
Numerous experimental and clinical studies have com-
pared the cytotoxicity of different fluoroquinolones, includ-
ing levofloxacin and moxifloxacin, but the results have 
been inconsistent. In contrast to our results, Kim, et al.12 re-
ported that levofloxacin (Cravit®) was less cytotoxic than 
moxifloxacin (Vigamox®) when these eyedrops were ex-
posed to cultured human corneal epithelial cells over 2 
hours. Tsai, et al.10 incubated human corneal epithelial cells 
with different fluoroquinolones (norfloxacin, ciprofloxacin, 
ofloxacin, levofloxacin, moxifloxacin and gatifloxacin) us-
ing both commercial ophthalmic formulations and raw ma-
terials (standard powders) of each antibiotic, and reported 
that levofloxacin and ofloxacin showed the least cytotoxici-
ty. In contrast, Sosa, et al.11 reported that among moxifloxa-
cin, gatifloxacin, ofloxacin, and levofloxacin, moxifloxacin 
showed the lowest degree of cytotoxicity in immortalized 
conjunctival and human corneal epithelial cells. In a clini-
cal study, Kovoor, et al.13 compared in vivo confocal mi-
croscopy images after instillation of either moxifloxacin, 
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Epithelial healing rates with topical ciprofloxacin, ofloxacin, and 
ofloxacin with artificial tears after photorefractive keratectomy. J 
Cataract Refract Surg 2000;26:690-4.
7. Moreira LB, Lee RF, de Oliveira C, LaBree L, McDonnell PJ. Ef-
fect of topical fluoroquinolones on corneal re-epithelialization af-
ter excimer laser keratectomy. J Cataract Refract Surg 1997;23: 
845-8.
8. Moshirfar M, Chew J, Werner L, Meyer JJ, Hunter B, Stevens S, 
et al. Comparison of the effects of fourth-generation fluoroquino-
lones on corneal re-epithelialization in rabbit eyes. Graefes Arch 
Clin Exp Ophthalmol 2008;246:1455-61. 
9. Kowalski RP, Kowalski BR, Romanowski EG, Mah FS, Thomp-
son PP, Gordon YJ. The in vitro impact of moxifloxacin and gati-
floxacin concentration (0.5% vs 0.3%) and the addition of benzal-
konium chloride on antibacterial efficacy. Am J Ophthalmol 
2006;142:730-5. 
10. Tsai TH, Chen WL, Hu FR. Comparison of fluoroquinolones: cy-
totoxicity on human corneal epithelial cells. Eye (Lond) 2010;24: 
909-17. 
11. Sosa AB, Epstein SP, Asbell PA. Evaluation of toxicity of com-
mercial ophthalmic fluoroquinolone antibiotics as assessed on im-
mortalized corneal and conjunctival epithelial cells. Cornea 2008; 
27:930-4. 
12. Kim SY, Lim JA, Choi JS, Choi EC, Joo CK. Comparison of anti-
biotic effect and corneal epithelial toxicity of levofloxacin and 
moxifloxacin in vitro. Cornea 2007;26:720-5.
13. Kovoor TA, Kim AS, McCulley JP, Cavanagh HD, Jester JV, 
Bugde AC, et al. Evaluation of the corneal effects of topical oph-
thalmic fluoroquinolones using in vivo confocal microscopy. Eye 
Contact Lens 2004;30:90-4.
14. Watanabe R, Nakazawa T, Yokokura S, Kubota A, Kubota H, 
Nishida K. Fluoroquinolone antibacterial eye drops: effects on 
normal human corneal epithelium, stroma, and endothelium. Clin 
Ophthalmol 2010;4:1181-7. 
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